235 related articles for article (PubMed ID: 20345569)
21. TRALI risk reduction: donor and component management strategies.
Eder AF; Benjamin RJ
J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816
[TBL] [Abstract][Full Text] [Related]
22. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
23. An association between ABO group and HLA antibody detection.
Dunbar NM; Yazer MH; Bravo MD; Kamel HT; Gorlin J; Norris PJ; Williamson PC; Vassallo RR;
Transfusion; 2017 Feb; 57(2):313-318. PubMed ID: 27807878
[TBL] [Abstract][Full Text] [Related]
24. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations.
Odent-Malaure H; Quainon F; Ruyer-Dumontier P; Ducroz S; Verdier P; Voitellier E; Raynal MF; Fromont P; Muller JY; Rebibo D; Absi L; Garraud O
Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109
[TBL] [Abstract][Full Text] [Related]
25. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
26. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury.
Toy P; Hollis-Perry KM; Jun J; Nakagawa M
Transfusion; 2004 Dec; 44(12):1683-8. PubMed ID: 15584980
[TBL] [Abstract][Full Text] [Related]
27. Results of HLA antibody testing using ELISA vs the fluorescent bead method and retrospective review of data for recipients of packed RBCs and platelets from male HLA-immunized donors.
Aung FM; Cano P; Fernandez-Vina M; Lichtiger B
Am J Clin Pathol; 2011 Jan; 135(1):90-5. PubMed ID: 21173129
[TBL] [Abstract][Full Text] [Related]
28. Analysis of cutoffs for screening sensitized blood donors for HLA alloantibodies using a cytometric microbead assay.
Makar RS; Saidman SL; Stowell CP; Lee H; Powers A
Transfusion; 2011 Jan; 51(1):166-74. PubMed ID: 20633246
[TBL] [Abstract][Full Text] [Related]
29. Presence of HLA antibodies in single-donor-derived fresh frozen plasma compared with pooled, solvent detergent-treated plasma (Octaplas).
Sinnott P; Bodger S; Gupta A; Brophy M
Eur J Immunogenet; 2004 Dec; 31(6):271-4. PubMed ID: 15548265
[TBL] [Abstract][Full Text] [Related]
30. Impact of using different laboratory assays to detect human leukocyte antigen antibodies in female blood donors.
Lopes LB; Fabron A; Chiba AK; Ruiz MO; Bordin JO
Transfusion; 2010 Apr; 50(4):902-8. PubMed ID: 20003053
[TBL] [Abstract][Full Text] [Related]
31. The prevalence of leucocyte alloantibodies in blood donors from South China.
Xia W; Ye X; Xu X; Chen D; Deng J; Chen Y; Ding H; Shao Y; Wang J; Liu J; Li H; Huang YF; Fu Y; Santoso S
Transfus Med; 2015 Dec; 25(6):385-92. PubMed ID: 26876912
[TBL] [Abstract][Full Text] [Related]
32. Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services.
Lin Y; Saw CL; Hannach B; Goldman M
Transfusion; 2012 Mar; 52(3):567-74. PubMed ID: 21895676
[TBL] [Abstract][Full Text] [Related]
33. HLA-DR antibodies in transfusion-related acute lung injury (TRALI): a case report.
Muro M; Rivera J; Botella C; Campillo JA; Ferrer F; Alvarez-López MR
Transfus Apher Sci; 2008 Jun; 38(3):209-12. PubMed ID: 18462996
[TBL] [Abstract][Full Text] [Related]
34. Transfusion-related acute lung injury: current concepts for the clinician.
Triulzi DJ
Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.
Arnold ML; Dechant M; Doxiadis II; Spriewald BM
Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575
[TBL] [Abstract][Full Text] [Related]
36. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC
Transplant Proc; 2009; 41(1):95-8. PubMed ID: 19249487
[TBL] [Abstract][Full Text] [Related]
37. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury.
; Bierling P; Bux J; Curtis B; Flesch B; Fung L; Lucas G; Macek M; Muniz-Diaz E; Porcelijn L; Reil A; Sachs U; Schuller R; Tsuno N; Uhrynowska M; Urbaniak S; Valentin N; Wikman A; Zupanska B
Vox Sang; 2009 Apr; 96(3):266-9. PubMed ID: 19207164
[TBL] [Abstract][Full Text] [Related]
38. Transfusion-related acute lung injury reports in the Netherlands: an observational study.
van Stein D; Beckers EA; Sintnicolaas K; Porcelijn L; Danovic F; Wollersheim JA; Brand A; van Rhenen DJ
Transfusion; 2010 Jan; 50(1):213-20. PubMed ID: 19694998
[TBL] [Abstract][Full Text] [Related]
39. Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.
Fontaine MJ; Kuo J; Chen G; Galel SA; Miller E; Sequeira F; Viele M; Goodnough LT; Tyan DB
Transfusion; 2011 Dec; 51(12):2611-8. PubMed ID: 21615749
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors.
Kakaiya RM; Triulzi DJ; Wright DJ; Steele WR; Kleinman SH; Busch MP; Norris PJ; Hillyer CD; Gottschall JL; Rios JA; Carey P; Glynn SA;
Transfusion; 2010 Jun; 50(6):1328-34. PubMed ID: 20070615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]